Literature DB >> 18536597

Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.

Ponnalagu Murugeswari1, Dhananjay Shukla, Anand Rajendran, Ramasamy Kim, Perumalsamy Namperumalsamy, Veerappan Muthukkaruppan.   

Abstract

PURPOSE: To investigate the mechanism of angiogenesis in proliferative diabetic retinopathy (PDR) and Eales' disease (ED) on the basis of the levels of proinflammatory cytokines, angiogenic growth factor, and antiangiogenic factor in the vitreous humor.
METHODS: Twenty-five patients with PDR, 10 patients with ED, and 25 with macular hole (MH) as control subjects were studied. The concentration of the proinflammatory cytokines interleukin-6 (IL-6), IL-8, IL-1 beta; chemokine-monocyte chemoattractant protein-1 (MCP-1); angiogenic factor-vascular endothelial growth factor (VEGF); and antiangiogenic factor-pigment epithelium derived factor (PEDF) in the vitreous fluid obtained from the eyes during vitrectomy were measured by sandwich enzyme linked immunosorbent assay (ELISA).
RESULTS: IL-6, IL-8, MCP-1, and VEGF levels in the vitreous were significantly higher in PDR (P < 0.0001) and ED (P < 0.0001) than in MH patients. Conversely, the vitreous level of PEDF was significantly reduced in PDR (P < 0.0001) but not in ED. A significant correlation was observed between VEGF and IL-6 in ED patients.
CONCLUSION: The authors demonstrate the importance of VEGF in retinal neovascularization of ED which is an idiopathic inflammatory venous occlusion. Further study is required to understand the interrelationship between VEGF and inflammatory cytokines in PDR and ED.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536597     DOI: 10.1097/IAE.0b013e31816576d5

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  70 in total

Review 1.  Mediators of ocular angiogenesis.

Authors:  Yureeda Qazi; Surekha Maddula; Balamurali K Ambati
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

2.  A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.

Authors:  G Srividya; M Jain; K Mahalakshmi; S Gayathri; R Raman; N Angayarkanni
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

3.  Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.

Authors:  Alicia J Jenkins; Dongxu Fu; Madona Azar; Julie A Stoner; Derrick G Kaufman; Sarah Zhang; Richard L Klein; Maria F Lopes-Virella; Jian-Xing Ma; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2014-01-17       Impact factor: 2.852

4.  Constitutive and LPS-induced expression of MCP-1 and IL-8 by human uveal melanocytes in vitro and relevant signal pathways.

Authors:  Dan-Ning Hu; Mingchao Bi; David Y Zhang; Fei Ye; Steven A McCormick; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

5.  Glutaredoxin regulates autocrine and paracrine proinflammatory responses in retinal glial (muller) cells.

Authors:  Melissa D Shelton; Anne M Distler; Timothy S Kern; John J Mieyal
Journal:  J Biol Chem       Date:  2008-12-12       Impact factor: 5.157

6.  Current and future management of diabetic retinopathy: a personalized evidence-based approach.

Authors:  Ryan J Fante; Thomas W Gardner; Jeffrey M Sundstrom
Journal:  Diabetes Manag (Lond)       Date:  2013-11-01

7.  Role of IL-6 in angiotensin II-induced retinal vascular inflammation.

Authors:  Modesto Rojas; Wenbo Zhang; Dexter L Lee; Maritza J Romero; Doan T Nguyen; Mohamed Al-Shabrawey; Nai-Tse Tsai; Gregory I Liou; Michael W Brands; Robert W Caldwell; Ruth B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

8.  Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy.

Authors:  Michal Laniado Schwartzman; Pavel Iserovich; Katherine Gotlinger; Lars Bellner; Michael W Dunn; Mauro Sartore; Maria Grazia Pertile; Andrea Leonardi; Sonal Sathe; Ann Beaton; Lynn Trieu; Robert Sack
Journal:  Diabetes       Date:  2010-04-27       Impact factor: 9.461

9.  Pro-angiogenic effect of IFNgamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells.

Authors:  Baoying Liu; Lisa Faia; Mengjun Hu; Robert B Nussenblatt
Journal:  Mol Vis       Date:  2010-02-10       Impact factor: 2.367

10.  Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.

Authors:  Banu Turgut Ozturk; Banu Bozkurt; Hurkan Kerimoglu; Mehmet Okka; Umit Kamis; Kemal Gunduz
Journal:  Mol Vis       Date:  2009-09-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.